Record highs in the Dow and S&P 500, a powerful chip stock rally, a stronger dollar and softer oil prices are reshaping where risk and opportunity may sit in large caps right now. To help make sense of it, this article focuses on three large cap blue chip stocks from our screener that appear especially exposed to these developments. These stocks may be affected in ways that could be either helpful or challenging, depending on your expectations and time frame. Each stock is backed by sizeable market value and established operations, giving you clearer reference points as you weigh what the latest headlines might mean for your portfolio.

Allegion (ALLE)

Overview: Allegion is a Dublin based security company that supplies locks, electronic access systems and related software to commercial buildings, institutions and homes worldwide, with well known brands such as Schlage, SimonsVoss and Von Duprin.

Operations: Allegion generates about US$3.3b from Allegion Americas and US$0.9b from Allegion International each year, with the Americas segment providing the bulk of its revenue.

Market Cap: US$12.0b

Allegion provides exposure to a large, cash generative security business within the “essential but often overlooked” part of the market, at a time when blue chip stocks are in focus. Growth in connected locks, access control software and recurring services is shifting the mix away from purely mechanical hardware, while a 1.56% dividend, active buybacks and a P/E below many peers highlight its income and valuation characteristics. At the same time, high leverage, softer residential demand and reliance on nonresidential construction create meaningful risks. How those strengths and pressure points develop, particularly with analysts differing on price targets and margins, is central to the ongoing investment narrative.

Allegion’s mix of cash generating security hardware, growing software and a 1.56% dividend is only half the story. The real tension sits in how its valuation stacks up against those strengths, and the DCF valuation analysis for Allegion hints at one number investors often overlook

ResMed (RMD)

Overview: ResMed is a San Diego based medical technology company that makes devices and cloud software to diagnose and treat sleep apnea and other breathing disorders, combining physical equipment like CPAP machines and masks with digital tools that help doctors and patients manage therapy from home.

Operations: ResMed generates about US$4.9b from its Sleep and Breathing Health segment and around US$0.7b from Residential Care Software, with sleep and breathing products providing the majority of revenue.

Market Cap: US$29.0b

ResMed stands out in a market that is rewarding large, high quality healthcare platforms, as it pairs sleep and respiratory hardware with sticky, recurring software and data services that support chronic disease management. The company has been active in acquisitions such as Noctrix Health to widen its sleep ecosystem, with recent commentary highlighting strong demand and efforts to work through past semiconductor and supply bottlenecks. At the same time, investors need to weigh reimbursement risk, competition from GLP 1 therapies and alternative treatments, and potential pricing pressure as more rivals re enter key markets. For investors trying to assess whether ResMed’s mix of recurring revenue, cash generation and growth expectations justifies its valuation, the analyst forecasts and margin assumptions are a central consideration.

ResMed’s mix of hardware and sticky software is attracting fresh attention, but the real story may sit in how growth expectations, reimbursement trends and GLP 1 risks intersect with the analyst forecasts for ResMed investors keep overlooking right now

CDW (CDW)

Overview: CDW is a Vernon Hills based IT solutions provider that helps businesses, governments, schools and healthcare organizations design, buy, implement and manage everything from laptops and servers to cloud, cybersecurity and managed services across the US, UK and Canada.

Operations: CDW generates about US$20.1b from its main operating segments and US$2.8b from Other activities, with most revenue coming from the United States at roughly US$20.0b and the rest of the world contributing about US$2.9b.

Market Cap: US$17.0b

CDW is drawing renewed interest as a large cap technology solutions provider that sits at the crossroads of AI infrastructure, cloud and cybersecurity spending, just as major indexes hit record highs and chip stocks lead the market. The company pairs a broad hardware and software offering with advisory and managed services, a stated 1.89% dividend and ongoing share repurchases, including a US$1.0b increase in authorization this year. At the same time, its capital structure, the impact of lower margin enterprise deals and revenue growth that trails the wider US market may lead some investors to focus carefully on entry points and expectations. The key consideration is how these characteristics, risk factors and recent institutional views fit together for long term holders.

CDW’s role at the heart of AI infrastructure, cloud and cybersecurity spending looks powerful, but the real story sits in how the analysis report for CDW ties its dividend, buybacks and capital structure together in one surprising twist

The three large cap blue chip stocks in this article are only a starting point, as the full screener surfaced 19 more companies with equally compelling stories inside the Large-Cap Blue Chip Stocks screener. Identify the catalysts that matter to you and analyze which combinations of value, dividends, financial health and past performance indicators line up with your highest conviction ideas on Simply Wall St.

Take Control of Your Investment Journey

If ResMed or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Alternatives Before Momentum Flies Past?

Fresh ideas often move first, then everyone notices. Use these curated stock shortlists to spot potential breakouts while they may still be under the radar.

• Target dependable income streams by scanning a curated group of high yield payers through the 7 dividend fortresses to keep returns in focus even when sentiment shifts.
• Explore the next wave of automation by checking the hand picked companies inside the 30 robotics and automation stocks that may benefit as robots and software reshape everyday operations.
• Review the carefully filtered 35 power grid technology and infrastructure stocks to find businesses tied to critical grid and energy projects.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.